Alkermes plc (Nasdaq: ALKS) and Clovis Oncology, Inc. (Nasdaq: CLVS) today announced positive preclinical data from a study designed to evaluate the combination potential of ALKS 4230, Alkermes'...

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for...

BERG, a clinical-stage biotech that employs artificial intelligence (AI) to research diseases and develop innovative treatments, today announced five presentations at the American Association for...

A news report by China.org.cn on 4th World Intelligence Congress: The 4th World Intelligence Congress (WIC), a top-level event in the field of intelligent technology, will open in north China's...

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™)...

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced positive...

Virtual Investor Conferences and KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional...

Sign up for a free registration to attend the Virtual Reality Franchise Expo (VRFE) at www.franexpousa.com taking place this Thursday June 25th between 11:00am-5:00pm EDT. Entrepreneurs from...

Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx: 2318; SSE: 601318) is pleased to announce that Ping An Property & Casualty Insurance Company of China,...

Global Association of Research Method and Data Science (RMDS) Lab today announced its industry-leading AI and data science annual conference – "IM DATA 2020" – will take on an entirely new...